We have demonstrated for the first time that the steroid metabolite, 2-methoxyestradiol (2-ME) is a powerful growth inhibitor of human osteosarcoma 143 B cell line by pleiotropic mechanisms involving cell cycle arrest at two different points and apoptosis.
Methoxyestradiol (2-ME) is a natural estrogenic metabolite formed by hydroxylation of estradiol followed by its O-methylation in the liver [1] . Previous studies showed that this estrogen has a cytotoxic effect on various proliferating cells in vitro [2] [3] [4] [5] [6] [7] [8] [9] and suppresses certain murine tumors in vivo [10] [11] [12] . 2-ME is also well known as an inhibitor of microtubule dynamics causing mitotic arrest [13, 14] followed by apoptosis [15] . The exact mechanism by which 2-ME inhibits target cell proliferation is still practically unknown. One of the postulated mechanisms for cytotoxic effect of 2-ME is its interference with the stability of
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59-65 QUARTERLY microtubules and the subsequent cell growth arrest in G 2 /M phase of the cell cycle [13, 14] . By contrast, quite dissimilar effects of 2-ME on cell-cycle distribution of breast cancer cells and prostate cancer cells have been observed. Treatment of breast cancer cells with 2-ME results in accumulation of cells in the G 1 phase [15] whereas prostate cancer cells show a marked accumulation of cells in the G 2 /M phase [12, 16] .
In this report we provide evidence for 2-ME concentration dependent mechanisms of perturbation of the cell cycle machinery at two different points of the osteosarcoma 143B cells.
MATERIALS AND METHODS
Reagents. Methoxyestradiol (2-ME), dimethyl sulfoxide (Me 2 SO) and Taxol were purchased from Sigma (St. Louis, MO, U.S.A.). Propidium iodide (PI) was from Molecular Probes (Eugene, OR, U.S.A.). DMEM (Dulbecco modified Eagle's medium) was from Nissui (Tokyo, Japan) and anti-acetylated tubulin antibodies (clone No. 6-11 B-1) were from Sigma (St. Louis, MO, U.S.A.).
Cell culture. 143B (TK [-] ) human osteosarcoma cells (r+) (ATCC CRL-8303) were cultured at 37°C in a humidified atmosphere with 5% CO 2 in Dulbecco's modified Eagle's medium containing 1 mM pyruvate, supplemented with 10% fetal bovine serum and 50 mg/ml kanamycin.
Cell cycle analysis. This was performed by flow cytometry, using nuclei labeled essentially according to Watabe et al. [17] . Cells were cultured on a 5 cm dish, harvested and washed with phosphate-buffered saline (PBS). Then DNA was stained with 500 ml of a PI solution containing 50 mg/ml of propidium iodide, 0.1% sodium citrate, 0.2% Nonidet P-40, supplemented with RNase (0.25 mg/ml) for 30 min at 4°C in the dark and then for 15 min at 37°C followed by flow cytometric analysis using a Coulter Epics XL flow cytometer (Coulter Corp., Miami, FL, U.S.A.). Cell-cycle distribution as measured by DNA content was analyzed for 10 000 cells for each culture. The relative proportion of cells in the G 1 , S and G 2 /M cell cycle phases were estimated by compartment analysis of DNA fluorescence using cell-cycle analysis software. Low-molecular mass DNA fluorescence was indicative of apoptotic cells. Two independent experiments were done in triplicate.
Caspase 3 (Apopain) activity assay. Cells were grown in 10 cm culture dishes. Caspase 3 activity was determined by Fluor Ace Apopain Assay Kit (Bio-Rad Laboratories, U.S.A.). Activity was monitored using the fluorogenic peptide substrate carbobenzoxy-Asp-Glu-Val-7-amino-4-trifluoromethyl coumarin (2-DEVD-AFC) [18] . Caspase 3 enzymatically cleaves the AFC from the peptide and releases free AFC, which then produces a blue-green fluorescence detectable at 500-550 nm with Bio-Rad VersaFluor Fluorometer. All procedures were performed following the manufacturer's instructions. Caspase 3 units were calculated as follows: DF/min´(calibration curve slope) -1´1 000. Cells were exposed to 1 mM 2-ME for 12 h and then cytosolic activity of caspase 3 was detected fluorometrically for the period of 3 h. Visualization of acetylated microtubules by confocal microscopy. Cells were permeabilized with 0.1% Triton X-100 in PBS for 10 min at room temperature, then blocked with 1% BSA in PBS, and incubated with monoclonal antibodies specific against acetylated tubulin (clone No. 6-11 B-1, Sigma) diluted 250-fold with blocking buffer, at room temperature for 1 h. In the next step the cells were incubated with the secondary antibodies (100d iluted) FITC-labelled goat anti-mouse IgG (Molecular Probes) at room temperature for 45 min. Coverslips were placed on glass slides in a Perma Fluor mounting solution (Immunon, Pittsburgh, PA, U.S.A.) and analyzed by a BioRad Lasersharp MRC 1024 scanning confocal microscope [19] . 60 J. Go³êbiewska and others 2002
RESULTS
Cells were treated for 24 h with 1 or 10 mM 2-ME and then stained with anti-acetylated tubulin antibodies for confocal microscopic analysis. The results presented on Fig. 1  (A-C) revealed a decrease of acetylated tubulin in the treated cells. Increases of monomeric tubulin background, together with a distinct decrease of the acetylated tubulin, can be easily detected (Fig. 1B, C) . Cells underwent mitotic arrest after exposition to 2-ME, becoming significantly enlarged and multinucleated (Fig. 1B, C) .
The above results confirmed the colchicine-like destabilizing effect of 2-ME on microtubules. 2-ME at 1 mM final concentration induced a significant arrest at G 1 phase Vol. 49 Effect of 2-methoxyestradiol on osteosarcoma 143B cells 61
Figure 1. Changes of acetylated tubulin in osteosarcoma 143B cells after treatment with 2-methoxyestradiol for 24 h.
A, Control; B, 1 mM and C, 10 mM 2-methoxyestradiol; scale bar = 10 mm; D, flow cytometric analysis of DNA fluorescence of PI-stained osteosarcoma 143B nuclei after 24 h of incubation with Taxol and 2-methoxyestradiol (2-ME).
(about 33% of cells) in human osteosarcoma 143B cells (Fig. 1D) . At 10 mM concentration 2-ME caused a marked shift from G 1 to G 2 /M phase indicative of the late cell cycle arrest (Fig. 1D) . Taxol displayed the very same effect on the cell cycle as 10 mM 2-ME (Fig. 1D) . Analysis of apoptosis revealed marked apoptotic (sub G 1 ) peak after 24 h of treatment with 10 mM 2-ME (Fig. 1D ). Cells treated with 1 mM 2-ME displayed a different pattern of cell cycle phase distribution, 33% of G 1 /G 0 being clearly visible (Fig. 2) . The sub-G 1 population (treated as an apoptosis marker) reached as much as 33% of the total cell population of osteosarcoma cells. At 10 mM concentration, accumulation of 58% of cells in G 2 /M phase was observed. Simultaneously, the S phase was depressed as compared with its level after treatment with 1 mM 2-ME (Fig. 2) . As on treatment with 2-ME the proportion of apoptotic cells was unexpectedly high, we decided to determine also caspase 3 activity. After treatment of cells for 12 h with 1 mM 2-ME the enzyme activity became significantly (over 5-fold) elevated (not shown).
DISCUSSION
The mechanism of 2-ME cytotoxic activity has been attributed to its ability to bind to the colchicine-binding site of tubulin resulting in altered stability of microtubules [20] . We demonstrated here that perturbation of microtubular stability by 10 mM 2-ME arrested asynchronously growing osteosarcoma cells at G 2 /M phase of the cell cycle. This arrest together with induction of apoptosis is a distinct mechanism of 2-ME action at its 10 mM concentration. Similar accumulation of prostate cancer and hepatoma cells in G 2 /M phase upon exposition to 5 mM or 10 mM 2-ME, respectively, has been also observed [12, 21] . Breast cancer cells, on the other hand, displayed a dissimilar cell cycle distribution pattern under the influence of 2-ME. When treated with submicromolar 2-ME the cells accumulated solely in G 1 phase [15] . The breast cancer cell line, being more sensitive to 2-ME than the prostate cancer and hepatoma cells, was treated with lower concentration of this drug [15] . Therefore we decided to study the effect of 2-ME on osteosarcoma cells exposed to the final concentration of the drug as low as 1 mM. At this 2-ME concentration we noticed a significant G 1 phase cell cycle arrest. Our study revealed a marked alteration of the level of acetylation of tubulin with a distinct decrease of the number of microtubules, which confirmed the colchicine-like destabilizing effect of 2-ME. Colchicine and vincristine act by inhibiting microtubule polymerization whereas Taxol causes formation of polymer with altered stability properties. The mechanism of 2-ME action appears to be more complex. This compound binds to both unpolymerized tubulin at the colchicine site and to the tubulin polymers at a less well-defined site [22] [23] [24] .
In conclusion, our results demonstrate that 2-ME shows a pleiotropic effect on 143B osteosarcoma cell line in a concentration dependent manner.
Multiple discrete mechanisms are involved in the cytotoxic action of 2-ME, including G 1 and G 2 /M cell cycle phase arrest, induction of caspase 3 activity and apoptosis. So far, the exact molecular mechanism of this process cannot be precisely described. 2-ME applied at 1 mM concentration to K562 cells activated proapoptotic SAPK kinase [25] .
The effect of 2-ME on cyclin B and cdc kinase activity may be considered a possible mechanism of cell cycle perturbation in osteosarcoma 143B cell line. Additional studies are required to elucidate the problem.
Vol. 49 Effect of 2-methoxyestradiol on osteosarcoma 143B cells
